Lordbregaflipped into Lordbrega’s Space, Science & NatureNew England Boston biotech conference led to 245,000 Covid-19 cases across US, genetic fingerprinting shows verified_publisherCNN(CNN) — A biotech conference in Boston last February that's already been flagged as a Covid-19 superspreading event led to at least 245,000 other cases across the US and Europe, a new genetic fingerprinting...
Nick Blakeflipped into Finger on the PulseCoronavirus (COVID-19) UK first to source coronavirus vaccines from biotech firms backed by Bill Gates verified_publisherTNW - David CanellisThe UK government revealed its stockpile of coronavirus (COVID-19) treatments on Monday, having recently secured 90 million doses of potential vaccines. Britain’s fresh agreement with Germany’s BioNTech...
Business Insiderflipped into Top StoriesReal EstateA biotech entrepreneur dropped $57 million on 2 adjacent homes in a Colorado ski resort town, shattering real estate records... verified_publisherBusiness Insider - Katie WarrenBiotech entrepreneur Kevin Ness just scooped up two adjacent properties in Vail, Colorado for $57.25 million, per Sotheby's International Realty. The purchase completely obliterated the ritzy ski town's...
AvatarDavidflipped into Daves MagGenetics Vancouver biotech firm AbCellera Biologics goes public at $20 per share on NASDAQ straight.com - Charlie Smith One of the shining lights of Vancouver's tech industry is now trading on one of North America's premier stock exchanges. AbCellera Biologics Inc. went …
TIMEflipped into Top StoriesChina ‘We Will Share Our Vaccine with the World.’ Inside the Chinese Biotech Firm Leading the Fight Against COVID-19 TIME - By Charlie Campbell / BeijingIt was the Chinese philosopher Sun Tzu, and not Al Pacino in The Godfather Part 2, who first said, “Keep your friends close, and your enemies closer.” Yin Weidong, the CEO of Chinese biotech firm SinoVac,...
National Postflipped into Financial NewsStock Markets Vancouver biotech developing COVID-19 drug like the one used to treat Trump soars in blockbuster IPO financialpost.com - Colin McClelland A Canadian biotech company that’s on the leading edge of COVID-19 therapies saw its stock price soar 185 per cent on its debut on Friday on the …
NPRflipped into HealthCorn As Biotech Crops Lose Their Power, Scientists Push For New Restrictions verified_publisherNPR - Dan CharlesSome of the most popular products of biotechnology — corn and cotton plants that have been genetically modified to fend off insects — are no longer offering the same protection from those bugs. Scientists...
GeekWireflipped into ScienceStartups Secretive Seattle biotech company raises more than $700M to develop new ways to modify genes geekwire.com - John Cook Sana Biotechnology today formally announced that it has raised more than $700 million in venture funding — one of the largest venture financing deals …
Forbesflipped into InnovationFungi This Biotech Startup Just Raised $47 Million To Make Drugs From Fungi Forbes - Leah RosenbaumIn 1928, a Scottish researcher by the name of Alexander Fleming came back from vacation to discover that he’d accidentally grown a species of fungi called Penicillium on a petri dish containing bacteria....
jilaxzoneflipped into Investing and InvestmentInvesting 2 Game-Changing Biotech Stocks That May Make You Rich verified_publisherThe Motley Fool - Adria Cimino From a painless vaccine to a method of fixing faulty genes, betting on these technologies may bring big rewards. Which biotech companies will become …
JerusalemPostflipped into Israel NewsMedical Conditions Israeli biotech firm's ALS treatment shows safety of use in trials jpost.com - By JERUSALEM POST STAFF Ness Ziona-based biotech firm Kadimastem has shown encouraging results of Cohort B of its Phase 1/2a clinical trial for AstroRx, its Amyotrophic …
The New York Timesflipped into WorldUnited States Superspreading Boston biotech conference in February is linked to 1.9 percent of all U.S. cases. verified_publisherThe New York Times - Amy HarmonAs many as 300,000 coronavirus cases across the United States can be traced to a two-day conference in Boston attended by 175 biotech executives in February, according to a study published Thursday in...
Global Newsflipped into Global NewsCoronavirus (COVID-19) Vancouver-based biotech company central in development of Pfizer COVID-19 vaccine Global News - Amy Judd A Vancouver company is central to the news Monday morning that Pfizer is close to developing an effective vaccine against the coronavirus. Pfizer said …
Business Insiderflipped into Top StoriesBiogen A $44 billion biotech just got some good news from the FDA about a key Alzheimer's drug, and the stock is soaring verified_publisherBusiness Insider - Barbara SmithThe biotech giant Biogen just said US regulators will give its potential Alzheimer's treatment a speedy review, sending the company's stock soaring. The US Food and Drug Administration will rule on the...
Nomiki Weitzelflipped into Health CareBiologySuper-secretive anti-aging biotech Calico tees up the first visible clinical trial of an experimental drug. And it’s for... endpts.com - John Carroll October 19, 2020 09:09 AM EDT Super-secretive anti-aging biotech Calico tees up the first visible clinical trial of an experimental …
Business Insiderflipped into MarketsCOVID-19 VaccineA little-known biotech working on a COVID-19 vaccine has surged 304% in 2 days — and it just said it was picked for the government's... verified_publisherBusiness Insider - Matthew Fox• Vaxart, a small-cap biotechnology company focused on developing oral vaccines administered by tablet rather than injection, said on Friday that it had been selected for the US government's Operation...
Oscar Seguradoflipped into Genomics & Gene Therapy 101Patents The two months in 1980 that shaped the future of biotech - STAT statnews.com - Henry T. Greely In the course of just under two months that started 40 years ago this week, five events occurred that shaped the biotechnology industry and …
Business Insiderflipped into InvestingFDA 2 biotech stocks plummet more than 25% after the FDA rejects their drug applications Business Insider - Matthew FoxGetty Images / Xinhua News Agency The FDA issued bad news to three biotechnology firms on Tuesday and Wednesday, sparking an investor exodus that sent shares tumbling. Gilead received a complete response...
Peak Bggrflipped into Biotech InvestingVaccinationModerna just finished recruiting 30,000 people for its coronavirus vaccine trial. One graph reveals how the biotech slowed... verified_publisherBusiness Insider - Andrew DunnThe Massachusetts biotech Moderna has finished recruiting volunteers for the final stage of clinical testing for its coronavirus vaccine candidate, the company said Thursday. The end results are promising...
Peak Bggrflipped into Biotech InvestingBiology Coronavirus and newfound fame: German biotechs in the spotlight verified_publisherDW News - Thomas Kohlmann Two German companies are at the forefront in the global race for a COVID-19 vaccine. But the potential of top German research could be used much more …
Matt Magnusonflipped into Investing. Holy Crap!Finance 3 Best Biotech Stocks to Buy Right Now verified_publisherThe Motley Fool - Jason Hawthorne Biotech is on every investor's mind as we move closer and closer to a successful vaccine for the coronavirus. Here are three contenders for your …
Guardian Australiaflipped into WorldKate Bingham UK's coronavirus vaccine taskforce chief faces questions over biotech fund verified_publisherThe Guardian - Mattha BusbyThe head of the government’s vaccine taskforce faces fresh questions after it emerged she hailed the launch of a biotechnology investment fund in her capacity as managing director of a venture capital...
Business Insiderflipped into Top StoriesPfizerPfizer teamed up with a tiny biotech to make a coronavirus vaccine, and we just got our first look at some promising but... verified_publisherBusiness Insider - STATAn experimental COVID-19 vaccine being developed by the drug giant Pfizer and the biotech firm BioNTech spurred immune responses in healthy patients, but also caused fever and other side effects, especially...
GeekWireflipped into ScienceWashington State Shares of Seattle biotech firm Omeros spike after reporting COVID-19 treatment results geekwire.com - Taylor Soper Omeros stock shot up more than 60% after the Seattle-based biotech company reported promising results from its COVID-19 drug treatment. The company …
